Valley News -

Local physician receives national designation


Last updated 9/6/2018 at 6:04pm


Dr. Richard Conner cuts a ceremonial ribbon with some of his partners and staff at Tri Valley Urology for receiving a national designation as a UroLift Center of Excellence.

MURRIETA – Dr. Richard Conner from Tri Valley Urology in Murrieta received a national designation, Aug. 21, as a UroLift Center of Excellence, giving men in the tri-valley area access to world class care for the treatment of enlarged prostate, also known as benign prostatic hyperplasia. This designation, which is awarded by Neotract, the makers of the UroLift system, is only presented to physicians who have obtained the highest level of training and expertise with this minimally invasive treatment and who have demonstrated a commitment to exemplary patient outcomes.

In 2018, there are well over 10,000 practicing urologists in the United States, and over 2,000 that have been trained to perform the Urolift system treatment. Currently there are only 75 physicians in the U.S. who have earned the Center of Excellence designation, and Conner in one of only eight physicians in all of Southern California, and the first in the area, to earn this distinction.

To celebrate the accomplishment, representatives from Neotract visited Conner's office Tuesday to present him with a plaque and to make the designation official with a ribbon-cutting ceremony. On hand for the event were many of Conner's partners and staff, his family, members of the local medical community and the executive leadership team from nearby Rancho Springs Medical Center.

"I am thrilled to be a UroLift Center of Excellence for the treatment of men suffering from enlarged prostate," Conner said. "The UroLift System is a revolutionary treatment that allows me to treat men in my office under local anesthesia. Unlike more invasive options, the UroLift System is a great option to taking daily BPH medications, and it provides men relief from their bothersome symptoms within days following the procedure."

Conner said that "earning this designation has been a total team effort, and I could not have done this without the support of my partners, the hard work and dedication from our amazing staff and the great partnership that we have with Rancho Springs."

Currently there are nearly 40 million men in the United States are affected by enlarged prostate. Not to be confused with prostate cancer, enlarged prostate occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

For many men, medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

NeoTract's UroLift System is cleared by the Food and Drug Administration. It is a minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia. The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating or removing prostate tissue.


Dr. Richard Conner prepares to cut the ribbon with members of the executive leadership team from Rancho Springs Medical Center, including from left to right, Dr Philip Brodak, CEO Brad Neet, Conner, Chief Nursing Officer Kristen Johnson, Associate Administrator Alistair Machoka and Chief Operating Officer Jared Giles, receiving a national designation as a UroLift Center of Excellence.

Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at

Tri Valley Urology is the Valley's source for urological care. Tri Valley Urology emphasizes on providing the most contemporary solutions for bladder, kidney and other urological diagnosis. More than providing the most up-to-date procedures, their providers strive for patient focused and driven care. Their goal is to continue to give the valley the most attentive, cutting-edge urological care for many years to come.

Submitted by Tri Valley Urology.


Reader Comments


Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2019